A systematic review and meta-analysis of randomized controlled trials, juxtaposing the control of glycemia and blood pressure between large dose empagliflozin and placebo among type 1 diabetes patients

OBJECTIVES: While empagliflozin (25 mg) is used to treat type-2 diabetes mellitus patients with optimum renal functioning, its efficacy and safety in type-1 diabetes mellitus (T1DM) is not yet established. Therefore, this study aimed to compare insulin-treated T1DM patients’ (with adequate renal fun...

Descripción completa

Detalles Bibliográficos
Autores principales: Saha, Sumanta, Saha, Sujata
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Qassim Uninversity 2020
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7069660/
https://www.ncbi.nlm.nih.gov/pubmed/32206059

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7069660/
https://www.ncbi.nlm.nih.gov/pubmed/32206059

Ejemplares similares